WallStSmart

Kopin Corporation (KOPN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 558% more annual revenue ($258.90M vs $39.32M). KOPN leads profitability with a 6.6% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

KOPN

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 3.3Quality: 5.0
Piotroski: 3/9Altman Z: -7.49

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOPNUndervalued (+5.0%)

Margin of Safety

+5.0%

Fair Value

$2.40

Current Price

$4.46

$2.06 discount

UndervaluedFair: $2.40Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOPN1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KOPN4 concerns · Avg: 3.5/10
Price/BookValuation
12.4x4/10

Trading at 12.4x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$660.47M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KOPN

The strongest argument for KOPN centers on Debt/Equity.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KOPN

The primary concerns for KOPN are Price/Book, EPS Growth, Market Cap. A P/E of 371.0x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KOPN profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

KOPN carries more volatility with a beta of 2.73 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 26/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kopin Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Kopin Corporation invents, develops, manufactures, and sells head and portable components, subassemblies, and systems in the United States, Asia-Pacific, Europe, and internationally. The company is headquartered in Westborough, Massachusetts.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?